
Keywords: فسفاتیدیلینواستیل 3'-kinase; AngII; angiotensin II; CKD; chronic kidney disease; EGF; epidermal growth factor; FGF; fibroblast growth factor; FGFR; fibroblast growth factor receptor; FRS2α; FGF receptor substrate 2α; HPG; heparan sulfate proteoglycans; IGF-1; insulin-like growth fa